Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic is seeking Food and Drug Administration ...

About half a year after announcing its intent to acquire a South Korean maker of tubeless insulin pump technology, Medtronic is scrapping the deal.. In an 8-K filing (PDF) with the U.S. Securities ...

The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...

Medtronic said on Thursday that it made two 510(k) submissions to the FDA: one for its MiniMed 780G insulin pump as an alternate controller enabled device, and another for its SmartGuard insulin ...

Products covered by the alert include the MiniMed Paradigm, MiniMed 600 series (640G, 670G) and MiniMed 700 series (770G, 780G) insulin pumps. However, insulin pump over- and under-delivery with ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Sept 20 (Reuters) - The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic (MDT.N), opens new tab were vulnerable to ...